Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd.

ENLV
Enlivex Therapeutics Ltd.US flagNASDAQ Capital Market
4.61
USD
-0.12
- -
77.60MMarket Cap

Enlivex Therapeutics Ltd. (ENLV) Stock Split History

Learn about Enlivex Therapeutics Ltd.'s most recent 1-for-15 basis stock split on July 09, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Enlivex Therapeutics Ltd.'s most recent stock split

Split Date: 2026-07-09
Split Ratio: 1:15
Price Before Split: $0.49
Price After Split: $0.03

Developer API

Get ENLV split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ENLV

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Enlivex Therapeutics Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-07-091:15Yes$0.49$0.03
2019-03-061:8Yes$1.41$0.18
2017-09-251:5Yes$0.35$0.07

About Enlivex Therapeutics Ltd.

Company overview and industry information

Enlivex Therapeutics Ltd. (ENLV) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Enlivex Therapeutics Ltd. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.